Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)400-403
JournalInternational Journal of Cardiology
Volume174
Issue number2
DOIs
Publication statusPublished - 1 Jan 2014

Cite this